PROTEIN ANTIGENS THAT PROVIDE PROTECTION AGAINST PNEUMOCOCCAL COLONIZATION AND/OR DISEASE
    6.
    发明公开
    PROTEIN ANTIGENS THAT PROVIDE PROTECTION AGAINST PNEUMOCOCCAL COLONIZATION AND/OR DISEASE 审中-公开
    蛋白抗原保护针对肺炎球菌定植和/或侵扰

    公开(公告)号:EP2953638A4

    公开(公告)日:2016-08-03

    申请号:EP14748672

    申请日:2014-02-07

    IPC分类号: A61K38/00

    摘要: The present application is generally directed to novel pneumococcal polypeptide antigens and nucleic acids encoding such antigens, and immunogenic compositions comprising such antigens for treating and preventing pneumococcal infection. The present invention further provides method of using the antigens to elicits an immune response (e.g., IL-17A response, a T cell-mediated and/or B-cell-mediated immune responses). The present invention also provides methods of prophylaxis and/or treatment of pneumococcal-mediated diseases, such as sepsis, comprising administering an immunogenic composition including one or more of a combination of pneumococcal antigens or functional fragments thereof as disclosed herein. In some embodiments, one or more pneumococcal antigens can be present in a polysaccharide conjugate. The compositions induce an anti-pneumoccocus immune response when administered to a mammal. The compositions can be used prophylactically to vaccinate an individual and/or therapeutically to induce a thereapeutic immune response to an infected individual.

    FUSED ANTIGEN VACCINES AND COMPOSITIONS AGAINST STREPTOCOCCUS PNEUMONIAE
    7.
    发明公开
    FUSED ANTIGEN VACCINES AND COMPOSITIONS AGAINST STREPTOCOCCUS PNEUMONIAE 有权
    新疆维吾尔族革命联合会

    公开(公告)号:EP2804627A4

    公开(公告)日:2015-12-30

    申请号:EP13738798

    申请日:2013-01-18

    IPC分类号: A61K39/09

    摘要: Streptococcus pneumoniae is a major health concern, especially in very young, elderly, or immunocompromised patients. The present disclosure provides, inter alia, certain highly effective vaccines and pharmaceutical compositions in Streptococcus pneumoniae that contain fusion proteins. The antigens may be used therapeutically or prophylactically.

    摘要翻译: 肺炎链球菌是一个主要的健康问题,特别是在非常年轻,老年或免疫功能低下的患者。 本公开尤其提供了含有融合蛋白的肺炎链球菌中的某些高效疫苗和药物组合物。 抗原可以用于治疗或预防。

    SYNERGISTIC IMMUNOGENIC FUSION PROTEIN-POLYSACCHARIDE CONJUGATE
    9.
    发明公开
    SYNERGISTIC IMMUNOGENIC FUSION PROTEIN-POLYSACCHARIDE CONJUGATE 审中-公开
    协同免疫原性融合蛋白,多糖结合

    公开(公告)号:EP2293815A4

    公开(公告)日:2013-04-03

    申请号:EP09751641

    申请日:2009-05-22

    IPC分类号: A61K39/385 A61K39/09

    摘要: An immunogenic composition comprising a fusion protein-polysaccharide conjugate consisting of a polysaccharide (PS) or pneumococcal bacterial cell wall polysaccharide (CWPS) conjugated to X:PdT where PdT represents the nonhemolytic variant of pneumolysin and X represents an antigenic peptide or protein of interest is provided. The immunity to X is synergistically enhanced by the fusion conjugate. Methods of protecting a subject from pneumococcal colonization or disease by administering an immunogenic composition including a fusion protein (PsaA:PdT) containing truncated PsaA and the nonhemolytic variant of pneumolysin (PdT) conjugated with CWPS (PsaA:PdT-CWPS) is also provided.